Alphabet Cl A (GOOGL) Holder American Research & Management Increased Stake by $1.52 Million as Stock Price Rose; Grandeur Peak Global Advisors Continues to Hold Stake in Veracyte (VCYT)

Alphabet Inc. (NASDAQ:GOOGL) Logo

American Research & Management increased its stake in Alphabet Inc Cl A (GOOGL) by 158.22% based on its latest 2018Q4 regulatory filing with the SEC. American Research & Management bought 1,454 shares as the company’s stock rose 5.64% with the market. The institutional investor held 2,373 shares of the programming company at the end of 2018Q4, valued at $2.48 million, up from 919 at the end of the previous reported quarter. American Research & Management who had been investing in Alphabet Inc Cl A for a number of months, seems to be bullish on the $825.23B market cap company. The stock decreased 0.19% or $2.23 during the last trading session, reaching $1190.3. About 2.59M shares traded or 42.52% up from the average. Alphabet Inc. (NASDAQ:GOOGL) has risen 7.65% since March 17, 2018 and is uptrending. It has outperformed by 3.28% the S&P500.

Grandeur Peak Global Advisors Llc increased its stake in Veracyte Inc (VCYT) by 475.22% based on its latest 2018Q4 regulatory filing with the SEC. Grandeur Peak Global Advisors Llc bought 259,681 shares as the company’s stock rose 65.23% with the market. The institutional investor held 314,325 shares of the health care company at the end of 2018Q4, valued at $3.95M, up from 54,644 at the end of the previous reported quarter. Grandeur Peak Global Advisors Llc who had been investing in Veracyte Inc for a number of months, seems to be bullish on the $890.41M market cap company. The stock increased 3.14% or $0.66 during the last trading session, reaching $21.66. About 1.87 million shares traded or 256.02% up from the average. Veracyte, Inc. (NASDAQ:VCYT) has risen 249.41% since March 17, 2018 and is uptrending. It has outperformed by 245.04% the S&P500. Some Historical VCYT News: 11/04/2018 – VERACYTE INC – FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED; 11/04/2018 – VERACYTE REPORTS PRECISION MEDICINE PACT WITH LOXO ONCOLOGY; 19/05/2018 – Veracyte Announces That Data From Multiple Studies Demonstrate “Real-World” Value of Afirma Genomic Sequencing Classifier in; 23/05/2018 – Veracyte: New Study Shows Afirma GSC’s Ability to Significantly Reduce Unnecessary Surgeries in Thyroid Cancer; 11/04/2018 – VERACYTE: LOXO TO USE ITS AFIRMA XPRESSION ATLAS PLATFORM; 17/04/2018 – Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on Tuesday, May 1, 2018; 19/05/2018 – Veracyte: Data From Studies Show ‘Real-World’ Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer; 17/05/2018 – Veracyte Launches Early Access Program for Envisia Genomic Classifier to Improve Diagnosis of IPF; 19/03/2018 – Veracyte Announces New Data Suggesting Afirma GSC’s Ability to Help Significantly More Patients Avoid Unnecessary Thyroid Surgery; 19/03/2018 – Veracyte Announces New Data Suggesting Afirma GSC’s Ability to Help Significantly More Patients Avoid Unnecessary Thyroid

More notable recent Alphabet Inc. (NASDAQ:GOOGL) news were published by: Investorplace.com which released: “Baidu Stock Investors Need Some Perspective Headed Into Today’s Q4 Results – Investorplace.com” on February 21, 2019, also Nasdaq.com with their article: “Alphabet (GOOGL) Dips More Than Broader Markets: What You Should Know – Nasdaq” published on March 14, 2019, Streetinsider.com published: “UPDATE: US State AGs Are Said to Take First Steps Toward Google (GOOGL) Probe – Bloomberg – StreetInsider.com” on March 15, 2019. More interesting news about Alphabet Inc. (NASDAQ:GOOGL) were released by: Nasdaq.com and their article: “Google Strengthens E-commerce Presence With JD.com’s Joybuy – Nasdaq” published on March 06, 2019 as well as Nasdaq.com‘s news article titled: “Google to Cash in on iPhone Craze to Boost Duplex User Base – Nasdaq” with publication date: March 11, 2019.

American Research & Management, which manages about $343.97 million and $296.69 million US Long portfolio, decreased its stake in Helmerich & Payne (NYSE:HP) by 8,010 shares to 33,335 shares, valued at $1.60M in 2018Q4, according to the filing. It also reduced its holding in Kinder Morgan Inc (NYSE:KMI) by 32,847 shares in the quarter, leaving it with 13,363 shares, and cut its stake in Emerging Lcl $ Bd Etf (EMLC).

Since October 31, 2018, it had 0 buys, and 6 insider sales for $3.01 million activity. Shares for $540,271 were sold by Hall Christopher M. JONES EVAN/ FA also sold $1.53M worth of Veracyte, Inc. (NASDAQ:VCYT) on Thursday, February 28.

Investors sentiment decreased to 1.37 in 2018 Q4. Its down 2.74, from 4.11 in 2018Q3. It worsened, as 7 investors sold VCYT shares while 39 reduced holdings. 28 funds opened positions while 35 raised stakes. 27.61 million shares or 48.87% less from 54.00 million shares in 2018Q3 were reported. Next Century Growth Limited Liability Com holds 0.96% or 534,966 shares in its portfolio. Acuta Capital Partners, a California-based fund reported 442,500 shares. Jpmorgan Chase reported 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT). State Street Corp reported 453,836 shares. Tower Research Cap (Trc) holds 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 3,334 shares. Trexquant Inv LP stated it has 13,132 shares. Timpani Cap Mngmt Ltd Com holds 0.54% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 75,912 shares. Ameritas Investment Partners Inc accumulated 2,344 shares. Alliancebernstein LP reported 28,400 shares or 0% of all its holdings. 4,087 are held by Royal Bank & Trust Of Canada. Parametric Port Limited Liability Co reported 94,387 shares. Los Angeles Cap Management Equity Rech reported 11,145 shares. Blackrock Inc reported 2.98M shares or 0% of all its holdings. 1,154 were reported by Dorsey Wright & Associate. Susquehanna Grp Limited Liability Partnership invested in 15,946 shares.

Veracyte, Inc. (NASDAQ:VCYT) Institutional Positions Chart